17
http://pistoiaalliance.org @PistoiaAlliance The Pistoia Alliance Update on Strategy & Progress Presentation to #BioIT12 Ramesh Durvasula, PhD Director, Informatics, Bristol-Myers Squibb Board Member of the Pistoia Alliance

The Pistoia Alliance: Update on Strategy and Progress

Embed Size (px)

DESCRIPTION

Ramesh Durvasula, Pistoia Alliance board member, discusses the Pistoia Alliance mission and recaps activities in 2011-12, with particular emphasis on the successful completion of the Sequence Squeeze Competition and Sequence Services Phase 2. The presentation was delivered at BioITWorld in Boston in April 2012.

Citation preview

Page 1: The Pistoia Alliance: Update on Strategy and Progress

http://pistoiaalliance.org @PistoiaAlliance

The Pistoia AllianceUpdate on Strategy & Progress

Presentation to #BioIT12

Ramesh Durvasula, PhDDirector, Informatics, Bristol-Myers Squibb Board Member of the Pistoia Alliance

Page 2: The Pistoia Alliance: Update on Strategy and Progress

Agenda

• Industry Drivers• The Origins of Pistoia• The Mission and Strategy of

Pistoia• The Initiatives of Pistoia

Page 3: The Pistoia Alliance: Update on Strategy and Progress

Rapidly Evolving Info Ecosystem

Big Life Science

Company

Yesterday Today Tomorrow

Yesterday Today Tomorrow

Innovation Model

Innovation inside Searching for InnovationHeterogeneity of collaborations.

Part of the wider ecosystem

IT Internal apps & dataStruggling with change

Security and TrustCloud/Services

Data Mostly inside Inside Outside Distributed

Portfolio Internally driven and owned

Partially shared Shared portfolio

Page 4: The Pistoia Alliance: Update on Strategy and Progress

What is Needed: Glue between Nodes

ProprietarycontentproviderPublic

contentprovider

Academicgroup

Software vendor

CRO

Service provider

Regulatoryauthorities

Page 5: The Pistoia Alliance: Update on Strategy and Progress

The Mission of the Pistoia Alliance

Lowering the barriers to innovation

by improving the interoperability of R&D business processes

via pre-competitive collaborations

Page 6: The Pistoia Alliance: Update on Strategy and Progress

Pistoia Alliance MembershipDec 2011

Page 7: The Pistoia Alliance: Update on Strategy and Progress

Chemistry Externalization Processes

Page 8: The Pistoia Alliance: Update on Strategy and Progress

Potential Projects

COLLABORATION BACKBONE

ORDERING/REQUESTING SERVICES

COLLABORATION

BROKERING ANIMLSIGNPO

ST

HOSTED ELN

SAMPLE MGT

HOSTED REGISTRATI

ON

Page 9: The Pistoia Alliance: Update on Strategy and Progress

Pistoia-Led Successes

• Sequence Services– Phase 1 (2011): 4 proofs of concept– Phase 2 (2012): 3 demos at Pistoia

Conference

• Semantic Enrichment of Scientific Literature– Transfer to IMI’s OpenPHACTS

• Sequence Squeeze– $15K prize for best new NGS compression

algorithm

Page 10: The Pistoia Alliance: Update on Strategy and Progress

www.sequencesqueeze.org

All source code from entries available on SourceForge under BSD-2 license

Page 11: The Pistoia Alliance: Update on Strategy and Progress

Sequence Squeeze Results & Winner

James BonfieldWellcome Trust Sanger Institute

Page 12: The Pistoia Alliance: Update on Strategy and Progress

A recent innovation attributed to Pistoia

• ODDT (Open Drug Discovery Teams) – an iPad app for rare and neglected disease collaboration that is chemistry-aware and uses social media

• Launched April 12, 2012• Presented @ ACS• Idea-innovation, 2 months

Page 13: The Pistoia Alliance: Update on Strategy and Progress

Pistoia Conference (24 April 2012)

• Twitter: #PistoiaCon12 @PistoiaAlliance

• Dragon’s Den, pitching new projects

• Review output of Sequence Services– Cycle Computing & Eagle Genomics– HP– Constellation Technologies & Genestack

Page 14: The Pistoia Alliance: Update on Strategy and Progress

Pistoia Alliance Publications

1. “The Pistoia Alliance - The Sequence Services Project” - Simon Thornber et al. - G.I.T. Laboratory Journal 1-2/2011

2. “Need for Collaborative Technologies in Drug Discovery” - Chris L. Waller et al. Book Chapter in “Collaborative Computational Technologies for Biomedical Research” – Edited by Sean Ekins et al. Wiley May 2011

3. “What are the obstacles to innovation in the Pharmaceutical Industry? The Pistoia Alliance responds” – The Pistoia Alliance – Drug Discovery World

4. “Empowering Industrial Research With Shared Biomedical Vocabularies” – Lee Harland et al - Drug Discovery Today in press

5. “ELNs - An Essential Productivity Tool – But Which One to Use” – John Wise - European Pharmaceutical Review - Issue 4, 2011

Page 15: The Pistoia Alliance: Update on Strategy and Progress

Pistoia Projects in the Pipeline

• Vocabulary standards• Biomarker exchange standards• Screening Data Standards • Canonical models for large molecules• Disease explorer• Data exchange with CROs

For more info, visit http://www.pistoiaalliance.org

Page 16: The Pistoia Alliance: Update on Strategy and Progress

A Reality Check: Setting Expectations

VS.

VS.

Page 17: The Pistoia Alliance: Update on Strategy and Progress

Our industry needs a Disruptive Innovation. That Disruption...is Pistoia

IF YOU WANT TO GO FAST, GO ALONEIF YOU WANT TO GO FAR, GO TOGETHER

www.pistoiaalliance.org

Twitter: @PistoiaAlliance